Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07031193 · ClinicalTrials.gov registry record · NA
Instructional Influence: How Cueing Alters Foam Rolling Outcomes
A NA study, sponsored by University of South Dakota.
- Not yet
- Registry status
- NA
- Development phase
- 52
- Enrollment target
NCT07031193: Clinical Trial NA study, sponsored by University of South Dakota.
NCT07031193 is a NA study that has not yet begun recruiting, run by University of South Dakota. The registered enrollment target is 52 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07031193, a NA study, has not yet begun recruiting, sponsored by University of South Dakota.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
Study Summary
Foam rolling (FR) is a common tool and procedure used in rehabilitation. Previous research has demonstrated physical improvements in range of motion and subjective reductions in pain post-intervention. Most of the literature theorizes potential biophysical reasons for these changes, but definitive studies are lacking. Another potential mechanism for these improvements may be psychological. The purpose of this study is to explore the psychological changes that occur in response to the instructions given to the patient and how these may influence the outcomes the individual receives while undergoing FR. Different instructions will be given for the same technique of FR to see if there are differences in changes with pain and range of motion.
Primary Outcome
Hamstring range of motion is measured with a standard goniometer on the dominant leg (the leg you would prefer to kick a ball with). Participant lying supine, the examiner assists with raising the leg straight (knee at 0 degrees extension) at the hip into flexion. Measure maximal hip flexion, with no change in knee extension, posterior pelvic tilt, or lumbar spine flexion. Goniometric measurements of hamstring length will then be measured with the stationary arm in line with the lateral midline
Interventions
- PROCEDURE Foam roller instructions for pain reduction
- PROCEDURE Foam rolling for range of motion improvement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2025-08-01 |
| Est. Completion | 2026-05-31 |
| Phase | NA |
What is known before NCT07031193 opens enrollment
NCT07031193 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 52 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Foam roller instructions for pain reduction is the first listed.
NCT07031193 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07031193 about?
NCT07031193 is a clinical study titled "Instructional Influence: How Cueing Alters Foam Rolling Outcomes". Foam rolling (FR) is a common tool and procedure used in rehabilitation. Previous research has demonstrated physical improvements in range of motion and subjective reductions in pain post-intervention. Most of the literature theorizes potential biophysical reasons for these changes, but definitive s...
What is the current status of trial NCT07031193?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 52 participants. The study started on 2025-08-01. Estimated completion is 2026-05-31.
What interventions are being tested in trial NCT07031193?
The interventions under investigation include: Foam roller instructions for pain reduction (PROCEDURE), Foam rolling for range of motion improvement (PROCEDURE).
Who is sponsoring clinical trial NCT07031193?
This trial is sponsored by University of South Dakota, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07031193's enrollment target sits among peer trials
52 1272nd of 2000 higher than 722 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI